Skip to main navigation Skip to search Skip to main content

Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer

  • Ali Raza Khaki
  • , Yong Shan
  • , Richard E. Nelson
  • , Sapna Kaul
  • , John L. Gore
  • , Petros Grivas
  • , Stephen B. Williams

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science